625 related articles for article (PubMed ID: 17602941)
1. ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis.
Finkielman JD; Lee AS; Hummel AM; Viss MA; Jacob GL; Homburger HA; Peikert T; Hoffman GS; Merkel PA; Spiera R; St Clair EW; Davis JC; McCune WJ; Tibbs AK; Ytterberg SR; Stone JH; Specks U;
Am J Med; 2007 Jul; 120(7):643.e9-14. PubMed ID: 17602941
[TBL] [Abstract][Full Text] [Related]
2. [Detection of antineutrophil cytoplasmic antibodies for the values of Wegener's granulomatosis diagnosis and activity judgment].
Zhang X; Jiang M; Chui J; Wang H; Ma J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Aug; 19(4):284-7. PubMed ID: 10453568
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study.
Csernok E; Holle J; Hellmich B; Willem J; Tervaert C; Kallenberg CG; Limburg PC; Niles J; Pan G; Specks U; Westman K; Wieslander J; De Groot K; Gross WL
Rheumatology (Oxford); 2004 Feb; 43(2):174-80. PubMed ID: 14585921
[TBL] [Abstract][Full Text] [Related]
4. Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study.
Boomsma MM; Stegeman CA; van der Leij MJ; Oost W; Hermans J; Kallenberg CG; Limburg PC; Tervaert JW
Arthritis Rheum; 2000 Sep; 43(9):2025-33. PubMed ID: 11014352
[TBL] [Abstract][Full Text] [Related]
5. Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitis.
Russell KA; Fass DN; Specks U
Arthritis Rheum; 2001 Feb; 44(2):463-8. PubMed ID: 11229478
[TBL] [Abstract][Full Text] [Related]
6. [Antineutrophil cytoplasmic autoantibodies in systemic vasculitis].
Hagemo JS; Aasarød K; Moen T
Tidsskr Nor Laegeforen; 2002 May; 122(12):1185-8. PubMed ID: 12089844
[TBL] [Abstract][Full Text] [Related]
7. Variations in performance characteristics of commercial enzyme immunoassay kits for detection of antineutrophil cytoplasmic antibodies: what is the optimal cut off?
Holle JU; Hellmich B; Backes M; Gross WL; Csernok E
Ann Rheum Dis; 2005 Dec; 64(12):1773-9. PubMed ID: 15843447
[TBL] [Abstract][Full Text] [Related]
8. Low seroprevalence and poor specificity of antineutrophil cytoplasmic antibodies in tuberculosis.
Teixeira L; Mahr A; Jaureguy F; Noël LH; Nunes H; Lefort A; Barry S; Deny P; Guillevin L
Rheumatology (Oxford); 2005 Feb; 44(2):247-50. PubMed ID: 15546964
[TBL] [Abstract][Full Text] [Related]
9. Antineutrophil cytoplasmic autoantibody in the absence of Wegener's granulomatosis or microscopic polyangiitis: implications for the surgical pathologist.
Gal AA; Velasquez A
Mod Pathol; 2002 Mar; 15(3):197-204. PubMed ID: 11904336
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous manifestations of Wegener's granulomatosis: a clinicopathologic study of 17 patients and correlation to antineutrophil cytoplasmic antibody status.
Comfere NI; Macaron NC; Gibson LE
J Cutan Pathol; 2007 Oct; 34(10):739-47. PubMed ID: 17880578
[TBL] [Abstract][Full Text] [Related]
11. IgG subclass distribution, affinity of anti-myeloperoxidase antibodies in sera from patients with Wegener's granulomatosis and microscopic polyangiitis.
Liu LJ; Chen M; Yu F; Zhao MH; Wang HY
Nephrology (Carlton); 2008 Oct; 13(7):629-35. PubMed ID: 18775059
[TBL] [Abstract][Full Text] [Related]
12. Value of a new automated fluorescence immunoassay (EliA) for PR3 and MPO-ANCA in monitoring disease activity in ANCA-associated systemic vasculitis.
Sinico RA; Radice A; Corace C; DI Toma L; Sabadini E
Ann N Y Acad Sci; 2005 Jun; 1050():185-92. PubMed ID: 16014533
[TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of elevated serum thrombomodulin and soluble E-selectin in patients with Wegener's granulomatosis and other systemic vasculitides.
Boehme MW; Schmitt WH; Youinou P; Stremmel WR; Gross WL
Am J Med; 1996 Oct; 101(4):387-94. PubMed ID: 8873509
[TBL] [Abstract][Full Text] [Related]
14. Antineutrophil cytoplasmic antibody measurement: advantages and disadvantages of a capture PR3 ELISA and a direct PR3 ELISA.
O'Donnell JL; Hayman MW; Spellerberg MB; McLellan AD; Brooksbank K; Chapman PT; Stamp LK
Pathology; 2007 Apr; 39(2):258-63. PubMed ID: 17454758
[TBL] [Abstract][Full Text] [Related]
15. Alternating antineutrophil cytoplasmic antibody specificity: drug-induced vasculitis in a patient with Wegener's granulomatosis.
Choi HK; Merkel PA; Tervaert JW; Black RM; McCluskey RT; Niles JL
Arthritis Rheum; 1999 Feb; 42(2):384-8. PubMed ID: 10025935
[TBL] [Abstract][Full Text] [Related]
16. Wegener's granulomatosis.
Lamprecht P; Gross WL
Herz; 2004 Feb; 29(1):47-56. PubMed ID: 14968341
[TBL] [Abstract][Full Text] [Related]
17. [Wegener's granulomatosis: otologic and clinico-immunologic aspects].
Kempf HG; Bootz F; Berg PA
Laryngorhinootologie; 1992 Jan; 71(1):26-30. PubMed ID: 1543518
[TBL] [Abstract][Full Text] [Related]
18. ANCA seropositivity in HIV: a serological pitfall.
Jansen TL; van Houte D; de Vries T; Wolthuis A
Neth J Med; 2005; 63(7):270-4. PubMed ID: 16093579
[TBL] [Abstract][Full Text] [Related]
19. [Wegener's granulomatosis in 2 adolescents].
van der Aa LB; van der Heide M; Sprikkelman AB; Brinkhorst G; Tytgat GA; van den Berg JM
Ned Tijdschr Geneeskd; 2007 Jul; 151(27):1522-6. PubMed ID: 17763812
[TBL] [Abstract][Full Text] [Related]
20. Detection and clinical implication of anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis and rapidly progressive glomerulonephritis.
Andrassy K; Koderisch J; Rufer M; Erb A; Waldherr R; Ritz E
Clin Nephrol; 1989 Oct; 32(4):159-67. PubMed ID: 2572369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]